EUVIMEDEUVIMED entdecken
Crossref

Metadherin with Stromal‐Immune Cues Drives CD36‐Dependent Lipid Reprogramming and Metastasis in Triple‐Negative Breast Cancer: Insights from a Hetero‐Spheroid Model

Soumyadeep Poddar iD, Shashikanta Sahoo, Yogesh Chandra, Sandeep Shrivastava, Srigiridhar Kotamraju iD, Biswajit Saha iD

Advanced Healthcare Materials · 2026-04 · 15 (14)

DOI: 10.1002/adhm.202504890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 28.01.2026. Verfasst von Soumyadeep Poddar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, CD36 Antigens, Spheroids, Cellular, RNA-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: DBT Ramalingaswami Re-Entry, CSIR, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple‐negative breast cancer (TNBC) exhibits altered lipid metabolism, driven by the tumor microenvironment's cancer‐associated fibroblasts (CAFs) and tumor‐associated macrophages (TAMs). CD36, a fatty acid translocase, is crucial in this metabolic adaptation of cancer cells. Despite its importance, what controls CD36‐mediated lipid flow is still unclear. This study identifies metadherin (MTDH), an oncogene, as a critical regulator of CD36‐dependent lipid exchange and TNBC progression. Using engineered spheroid models that mimic tumor microenvironment with MTDH‐Wt and MTDHΔ7 overexpressing TNBC cells co‐cultured with CAFs and TAMs, we observed increased lipid uptake, enhanced EMT, and aggressive metastatic features driven by MTDH‐CD36 signaling. Further analyses, including advanced microscopy and transcriptomics, revealed that MTDHΔ7 overexpression in TNBC cells in the presence of stromal‐immune cells, amplifies lipid metabolic pathways, promotes stemness, and pro‐metastatic signaling. Intriguingly, increased formation of tunnelling nanotube‐like structures, indicative of metabolic rewiring, was observed in Lv.MTDHΔ7‐MDA‐MB‐231 CAF‐TAM heterotypic spheroids. These changes were reversed by sulfosuccinimidyl oleate (SSO; CD‐36 inhibitor) treatment. Moreover, SCID mice bearing Lv.MTDH‐Wt/Δ7‐MDA‐MB‐231cells CAF‐TAM heterotypic spheroids led to accelerated breast tumor growth and lipid‐driven metastasis. Importantly, SSO administration significantly reduced lipid accumulation and tumor aggressiveness, confirming CD36 as a functional mediator of MTDH‐driven lipid reprogramming. Our findings establish MTDH as a master regulator of lipid reprogramming through CD36, a process further amplified by CAF‐TAM interactions, which creates a lipid‐rich tumor microenvironment fuelling TNBC aggressiveness. This study reveals crucial mechanistic insights into how stromal‐immune cells induce lipid symbiosis and highlights the MTDH‐CD36 axis as a promising therapeutic target for future combination therapies in aggressive, metabolically reprogrammed TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsCD36 AntigensSpheroids, CellularRNA-Binding ProteinsLipid MetabolismMembrane ProteinsCell Adhesion MoleculesHumansFemaleTumor MicroenvironmentCell Line, TumorAnimalsMetabolic ReprogrammingCancer-Associated FibroblastsMiceNeoplasm MetastasisSignal Transduction

Stichwörter der Autor:innen

CD36MTDHTNBCheterotypic spheroidslipid reprogramming

Substanzen

CD36 AntigensMTDH protein, humanRNA-Binding ProteinsMembrane ProteinsCell Adhesion MoleculesCD36 protein, human

Autor:innen und Institutionen

  • Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India.
  • Academy of Scientific and Innovative Research, Ghaziabad, India.
  • CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.
  • School of Biosciences, Engineering and Technology, Vellore Institute of Technology, Madhya Pradesh, India.

ORCID-Profile: Soumyadeep Poddar, Srigiridhar Kotamraju, Biswajit Saha

Förderung

  • DBT Ramalingaswami Re-Entry
  • CSIR, India

Zitieren

APA

Poddar, S., Sahoo, S., Chandra, Y., Shrivastava, S., Kotamraju, S., & Saha, B. (2026). Metadherin with Stromal‐Immune Cues Drives CD36‐Dependent Lipid Reprogramming and Metastasis in Triple‐Negative Breast Cancer: Insights from a Hetero‐Spheroid Model. Advanced Healthcare Materials, 15(14). https://doi.org/10.1002/adhm.202504890

Vancouver

Poddar S, Sahoo S, Chandra Y, Shrivastava S, Kotamraju S, Saha B. Metadherin with Stromal‐Immune Cues Drives CD36‐Dependent Lipid Reprogramming and Metastasis in Triple‐Negative Breast Cancer: Insights from a Hetero‐Spheroid Model. Advanced Healthcare Materials. 2026;15(14). doi:10.1002/adhm.202504890

BibTeX
@article{Poddar2026,
  author = {Poddar, Soumyadeep and Sahoo, Shashikanta and Chandra, Yogesh and Shrivastava, Sandeep and Kotamraju, Srigiridhar and Saha, Biswajit},
  title = {Metadherin with Stromal‐Immune Cues Drives CD36‐Dependent Lipid Reprogramming and Metastasis in Triple‐Negative Breast Cancer: Insights from a Hetero‐Spheroid Model},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {14},
  doi = {10.1002/adhm.202504890}
}
Kostenlos starten →